Viatris (VTRS) competitors & alternatives
Health Care · NASDAQ
Viatris (VTRS)'s top competitors and alternatives — its most similar public companies — include Organon & Co. (OGN), XOMA ROYALTY CORP (XOMA), Kraft Heinz (KHC), Kimberly-Clark (KMB), INHIBIKASE THERAPEUTICS INC (IKT), Mondelez International (MDLZ), AMNEAL PHARMACEUTICALS INC CLASS A (AMRX), Johnson & Johnson (JNJ), Lilly (Eli) (LLY), Amgen (AMGN), ASTRAZENECA PLC (AZN) and Cencora (COR). These are Viatris's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top VTRS competitors & alternatives
-
Organon & Co.OGNHealth Care
A diversified pharmaceutical company spun from Merck focusing on established branded medicines and medical devices for women's health, infectious disease, and…
$13.52 (as of 2026-07-22) · market cap $3.6B
-
XOMA ROYALTY CORPXOMAHealth Care
A lean-infrastructure royalty aggregator that generates non-dilutive capital for biotech developers in exchange for long-duration milestone and royalty rights…
$40.17 (as of 2026-07-21) · market cap $710M
-
Kraft HeinzKHCConsumer Staples
Kraft Heinz is a global food and beverage giant managing a diverse portfolio of iconic household brands, currently navigating a transformation strategy and…
$25.96 (as of 2026-07-22) · market cap $30.8B
-
Kimberly-ClarkKMBConsumer Staples
A global consumer staples powerhouse manufacturing essential personal care, family care, and professional products across 175+ countries through iconic brands…
$108.88 (as of 2026-07-22) · market cap $36.2B
-
INHIBIKASE THERAPEUTICS INCIKTHealth Care
A pre-revenue biotech company developing IKT-001, a novel therapeutic targeting pulmonary arterial hypertension, currently in Phase 3 clinical trials with no…
$2.17 (as of 2026-07-22) · market cap $287M
-
Mondelez InternationalMDLZConsumer Staples
A leading global snacking powerhouse with a portfolio of iconic chocolate and biscuit brands, driven by a focus on sustainable, consumer-centric growth.
$60.86 (as of 2026-07-22) · market cap $77.3B
-
AMNEAL PHARMACEUTICALS INC CLASS AAMRXHealth Care
Amneal Pharmaceuticals is a diversified biopharma company providing a broad range of essential, affordable generic and specialty medicines, alongside…
$17.75 (as of 2026-07-22) · market cap $5.7B
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$255.63 (as of 2026-07-22) · market cap $614.6B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,163.01 (as of 2026-07-22) · market cap $1.09T
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$366.05 (as of 2026-07-22) · market cap $197.7B
-
ASTRAZENECA PLCAZN
Leading global biopharmaceutical company developing targeted oncology, cardiovascular, and rare disease treatments backed by a strong R&D pipeline.
$169.73 (as of 2026-07-22) · market cap $193.7B
-
CencoraCORHealth Care
North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs,…
$300.58 (as of 2026-07-22) · market cap $58.5B
Not quite? Describe exactly what you want →
Peers are Viatris's closest public companies by shared sub-industry, sector and business themes. See the full profile: Viatris (VTRS).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.